News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development



4/27/2011 8:31:32 AM

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing novel drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that Kathryn J. Gregory has been appointed Vice President of Business Development. Ms. Gregory has more than 20 years of experience in international business development with a proven track record of negotiating deals and partnerships.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES